Unknown

Dataset Information

0

Spending on Targeted Therapies for Duchenne Muscular Dystrophy.

ABSTRACT:

SUBMITTER: Bendicksen L 

PROVIDER: S-EPMC10928534 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Spending on Targeted Therapies for Duchenne Muscular Dystrophy.

Bendicksen Liam L   Kesselheim Aaron S AS   Rome Benjamin N BN  

JAMA 20240401 13

Similar Datasets

Unknown Duchenne muscular dystrophy: current cell therapies.
| S-EPMC4480531 | biostudies-literature
Unknown Cardiac therapies for Duchenne muscular dystrophy.
| S-EPMC10328182 | biostudies-literature
Unknown Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.
| S-EPMC4036820 | biostudies-literature
Unknown Use of advanced heart failure therapies in Duchenne muscular dystrophy.
| S-EPMC6663084 | biostudies-literature
Unknown Duchenne muscular dystrophy.
| S-EPMC10557455 | biostudies-literature
Unknown Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies.
| S-EPMC6024668 | biostudies-literature
Unknown The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
| S-EPMC6586144 | biostudies-literature
Unknown Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy.
| S-EPMC8355726 | biostudies-literature
Unknown Theragnosis for Duchenne Muscular Dystrophy.
| S-EPMC8209366 | biostudies-literature
Unknown Gene Therapy for Duchenne Muscular Dystrophy.
| S-EPMC8673537 | biostudies-literature